Literature DB >> 18662728

Extracellular vesicles containing virus-encoded membrane proteins are a byproduct of infection with modified vaccinia virus Ankara.

Danièle Spehner1, Robert Drillien.   

Abstract

Vaccinia virus is a structurally complex virus that multiplies in the cell cytoplasm. The assembly of Vaccinia virus particles and their egress from infected cells exploit cellular pathways. Most notably, intracellular mature viral particles are enwrapped by Golgi-derived or endosomal vesicles. These enveloped particles, enriched in virus-encoded proteins, migrate to the cell surface where they are released into the extracellular space through fusion of their outer envelope with the cell membrane. We report that baby hamster kidney cells productively infected with the modified vaccinia virus Ankara strain (MVA) also release extracellular vesicles containing virus-encoded envelope proteins but devoid of any virus cargo. Such vesicles were visualized on the cell surface by electron microscopy and immunogold labelling of the B5 envelope protein. A portion of the B5 protein was found to be associated with non-viral material in high speed ultracentrifugation pellets and displayed a buoyant density characteristic of exosomes released by some cell types. An unrelated transmembrane protein (CD40 ligand) encoded by the MVA genome was also incorporated into extracellular vesicles but not into the envelopes that surround extracellular enveloped virus. High speed pellets obtained by centrifugation of culture medium from cells infected with MVA encoding CD40 ligand displayed the ability to induce dendritic cell maturation suggesting that the ligand is on the outer surface of the extracellular vesicles. We propose that the formation of extracellular vesicles after vaccinia virus infection is a byproduct of the pathway leading to the formation of extracellular enveloped virus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662728     DOI: 10.1016/j.virusres.2008.07.003

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

Review 1.  Microvesicles and viral infection.

Authors:  David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

2.  Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.

Authors:  Marc Schweneker; Andrea S Laimbacher; Gert Zimmer; Susanne Wagner; Elisabeth M Schraner; Michael Wolferstätter; Marieken Klingenberg; Ulrike Dirmeier; Robin Steigerwald; Henning Lauterbach; Hubertus Hochrein; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

3.  The relationship between serum exosome HBV-miR-3 and current virological markers and its dynamics in chronic hepatitis B patients on antiviral treatment.

Authors:  Weiqiang Gan; Xi Chen; Zeqian Wu; Xiang Zhu; Jing Liu; Tong Wang; Zhiliang Gao
Journal:  Ann Transl Med       Date:  2022-05

4.  Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.

Authors:  Danyang Gong; Xinghong Dai; Yuchen Xiao; Yushen Du; Travis J Chapa; Jeffrey R Johnson; Xinmin Li; Nevan J Krogan; Hongyu Deng; Ting-Ting Wu; Ren Sun
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  The microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytes.

Authors:  Sarah K Mercier; Heather Donaghy; Rachel A Botting; Stuart G Turville; Andrew N Harman; Najla Nasr; Hong Ji; Ulrike Kusebauch; Luis Mendoza; David Shteynberg; Kerrie Sandgren; Richard J Simpson; Robert L Moritz; Anthony L Cunningham
Journal:  PLoS Pathog       Date:  2013-10-17       Impact factor: 6.823

6.  Influence of cellular trafficking pathway on bluetongue virus infection in ovine cells.

Authors:  Bishnupriya Bhattacharya; Cristina C Celma; Polly Roy
Journal:  Viruses       Date:  2015-05-13       Impact factor: 5.048

Review 7.  The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma.

Authors:  Jiliang Shen; Chiung-Kuei Huang; Hong Yu; Bo Shen; Yaping Zhang; Yuelong Liang; Zheyong Li; Xu Feng; Jie Zhao; Lian Duan; Xiujun Cai
Journal:  J Cell Mol Med       Date:  2017-02-22       Impact factor: 5.310

8.  Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity.

Authors:  Henning Lauterbach; Juliane Pätzold; Ronny Kassub; Barbara Bathke; Kay Brinkmann; Paul Chaplin; Mark Suter; Hubertus Hochrein
Journal:  Front Immunol       Date:  2013-08-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.